adding veliparib to chemotherapy improved response rates
Published 7 years ago • 60 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:46
combination of veliparib and chemotherapy in brca-positive breast cancer
-
5:40
combination veliparib and chemotherapy in ovarian cancer
-
1:55
rationale for chemotherapy plus veliparib in frontline treatment of ovarian cancers
-
4:22
veliparib misses pfs endpoint, advances to phase iii trial
-
3:47
parp inhibitory velaparib trialled in brca1/2 breast cancer
-
4:15
improving chemotherapy response rates for melanoma patients
-
8:51
impact of adding bevacizumab to presurgery chemo for 3n bc varies with subtype
-
3:50
comment: veliparib with carboplatin and paclitaxel in advanced gbrca-positive breast cancers
-
0:52
revolutionizing cancer therapy
-
1:33:36
antibody therapy in all: how and why to integrate antibody-based treatment into patient management
-
29:51
evaluating clinical pathways for ovarian cancer treatment and maintenance therapy
-
36:01
choosing wisely in neoadjuvant treatment for different cancers in the philippines
-
8:50
case 4: chemotherapy or parp inhibitors for brca tnbc
-
1:25:21
novel strategies in cancer therapy
-
0:35
types of chemotherapy used for treatment of advanced cancers and metastases #chemotherapy #cancer
-
54:48
updates in molecular therapy for gi cancers - h. k. sanoff - 20220223
-
42:00
prospects for targeted therapy in ovarian cancer - by michael birrer, md, phd
-
1:09:38
upgrading the sequential therapy tool kit for b-cell malignancies
-
4:47
phase iii study of veliparib with carboplatin and paclitaxel in her2-negative advanced/metastati...